This raised the question of what a positive signal in such an array means, and to guide subsequent exploratory studies, we determined whether a positive signal in a multiplex assay has an additive value over commercial assays determining the presence of ACPA and whether these patients share the characteristics of RA patients positive in commercial ACPA assays. This evidence concerns the gene PRTN3 and rheumatoid arthritis.